Rhythm Pharmaceuticals, Inc. RYTM
Set alert
93.44 USD +0.87 +0.94%
At close
89.50 -3.94 -4.22%
Pre-market · Nov 3, 8:47 AM ET
93.04 Day range 95.06
74.50 52-week range 122.20
- YTD
- -12.71%
- 1 year
- -17.85%
- Open
- 93.13
- Prev close
- 92.57
- Mkt cap
- 6.41B
- Vol
- 2.00M
- Avg vol
- 675.20K
- EPS
- -3.12
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 93.04
- High
- 95.06
- Forward P/E
- -148.67
- Beta
- 2.13
- Short ratio
- 13.64
- Inst. own
- 115.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 97.18
- 200-d avg
- 97.09
- 1y target
- 140.53
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 140.53 +50.4% upside
Now 93.44
- Target (low)
- 120.00
- Target (mean)
- 140.53
- Target (high)
- 160.00
Ratings (0m) 19 17 buy · 2 hold · 0 sell
- Strong buy5
- Buy12
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 19
- 1 month ago 18
- 2 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.74252 | -0.85 – -0.66 | -0.82 | +9.4% | 84.60M | +64.9% | 13 |
| Next quarter | -0.72859 | -0.93 – -0.57 | -0.73 | +0.2% | 99.17M | +73.2% | 13 |
| Current year | -3.04 | -3.36 – -2.82 | -3.11 | +2.1% | 315.27M | +66.1% | 13 |
| Next year | -0.6285 | -2.45 – 0.49 | -3.04 | +79.3% | 565.12M | +79.3% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 15, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 28, 2026 | Deutsche Bank | Initiated | — | Hold |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 27, 2026 | JP Morgan | Initiated | — | Overweight |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 16, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 15, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 20, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 20, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 18, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 17, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 17, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 17, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 17, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 17, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 17, 2026 | Needham | Maintained | Buy | Buy |
| Mar 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 2, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |